Annual Reports and Accounts 2009/10


  • Home
    • |
  • Overview
    • |
  • Business Review
    • |
  • Governance
    • |
  • Financial Statements
    • |
  • Shareholder Information

Home / Sitemap

  • Sitemap

Sitemap

  • HOME
  • OVERVIEW
    • Highlights
    • About us
    • Core purpose, values and strategy
    • Chairman and Chief Executive's report
    • Financial review
  • BUSINESS REVIEW
    • Delivering drugs that transform lives
    • Markets
    • Products
    • Product pipeline
    • Enabling technologies
    • Capabilities
    • Key performance indicators
    • Risk management
  • GOVERNANCE
    • Corporate governance statement
    • Board of Directors
    • Executive management
    • Corporate Social Responsibility
    • Report on remuneration
    • Directors' report
  • FINANCIAL STATEMENTS
    • Statement of Directors' responsibilities
    • Independent auditors' report
    • Consolidated statement of comprehensive income
    • Consolidated balance sheet
    • Consolidated cash flow statement
    • Consolidated statement of changes in equity
    • Company balance sheet
    • Company cash flow statement
    • Company statement of changes in equity
    • Notes to the financial statements
    • Five-year summary
  • SHAREHOLDER INFORMATION
    • Shareholder information

Copyright 2010 Vectura group plc | Accessibility | Disclaimer and privacy policy | Sitemap

Registered number: 03418970 Registered office: Vectura Group plc, One Prospect West, Chippenham, Wiltshire SN14 6FH

Site by the Design Portfolio Online Services